Clinical Translation and Clinical Data Analysis

Take advantage of our unique access to primary patient samples for developing novel therapies and diagnostics from preclinical to clinical stages.

We are partnered with numerous clinical networks to provide:

• Integration in clinical study groups on different cancer types and access to key opinion leaders
• Custom recruitment of primary patient material:
  • Different tumor entities, stages, treatment resistances etc.
  • Metastatic tissue, malignant effusions and primary tumors including tumor microenvironment
  • Liquid biopsy: blood, bone marrow and cerebrospinal fluid (disseminated and circulating tumor cells (DTC/CTC), cell-free DNA (cfDNA), and tumor exosomes)
  • FFPE material
  • Longitudinal sampling/follow-up information

• GDPR-compliant access
• Sample logistics workflows for different organ types and analyses

We are skilled at integrating and analyzing complex patient data across various clinical and research institutions to improve diagnostic and therapeutic options for patients.

• Harmonized structure for clinical, omics, imaging, and drug testing data from various institutions
• Validated data analysis pipelines to gain valuable insights from complex data sets
• Consolidated research and development of analytical methods, machine learning, and AI tools
• GDPR-compliant data access and analysis